跳至主要内容
临床试验/KCT0007654
KCT0007654撤回未知

Hyperbaric oxygen therapy for the brain fog of long COVID

Myongji Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
撤回
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 70(Year)(—)
性别
All

入选标准

  • 1) More than 12 weeks have passed since the date of COVID-19 confirmed by RT-PCR
  • 2) Brain fog symptoms occurred within 6 months of being confirmed by the COVID-19 and have persisted until now.
  • 3) Age between 30 ~70 yrs
  • 4) Proficient in Korean
  • 5) A person who has consented to this participation and prepared a written consent before the start of the human application test

排除标准

  • 1) History of head trauma accompanied by loss of consciousness, stroke, epilepsy, dementia and other brain diseases
  • 2) Currently undergoing cancer treatment (surgery, chemotherapy, radiation)
  • 3) Serious heart disease (myocardial infarction, angina pectoris, severe arrhythmia), lung disease (chronic obstructive pulmonary disease, emphysema, asthma, pneumothorax), and other serious medical conditions
  • 4) Currently alcoholic or drug dependent, or have been diagnosed with schizophrenia.
  • 5) Otitis media, severe rhinitis, and problems with normal ear pressure control
  • 6) A person judged by the investigator to be inappropriate for this human application test

研究者

相似试验